The ViaDerma Inc (OTCMKTS:VDRM) stock was on the move on Thursday and rallied by as much as 32% after the company made an announcement with regards to an important deal.
ViaDerma announced that it is currently at the final stages of discussions with regards to an initial order for its wound care product named Vitastem from a well-known healthcare network. Vitastem had been tested successfully by the healthcare network last year and has now given approval for the purchase.
It is a major development for ViaDerma, considering the fact that once the initial purchase order is fulfilled, the product is going to be made available at a large number of hospices, hospitals, and nursing homes. However, that is not all. It has also emerged that ViaDerma is currently in discussions with another entity with regards to a licensing deal for its products. Investors could consider keeping a close eye on the ViaDerma stock today.